Clinical Trial Update: A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms

View source ↗

Summary

Prospective, single-arm clinical trial evaluating Restrata, an electrospun fiber matrix, for treatment of surgical defects after resection of malignant cutaneou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Cancer

Drugs mentioned

• Restrata Electrospun Fiber Matrix

Snippet

Sponsor: Acera Surgical, Inc. | Conditions: Surgical Wound | Status: RECRUITING